Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Inventory (2020 - 2025)

Historic Inventory for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $30.4 million.

  • RxSight's Inventory rose 3631.96% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year increase of 3631.96%. This contributed to the annual value of $22.6 million for FY2024, which is 2626.0% up from last year.
  • According to the latest figures from Q3 2025, RxSight's Inventory is $30.4 million, which was up 3631.96% from $26.7 million recorded in Q2 2025.
  • RxSight's Inventory's 5-year high stood at $30.4 million during Q3 2025, with a 5-year trough of $8.1 million in Q4 2021.
  • For the 5-year period, RxSight's Inventory averaged around $17.9 million, with its median value being $18.4 million (2023).
  • Per our database at Business Quant, RxSight's Inventory crashed by 531.15% in 2021 and then soared by 11328.25% in 2023.
  • RxSight's Inventory (Quarter) stood at $8.1 million in 2021, then surged by 89.87% to $15.5 million in 2022, then rose by 15.83% to $17.9 million in 2023, then grew by 26.26% to $22.6 million in 2024, then surged by 34.32% to $30.4 million in 2025.
  • Its last three reported values are $30.4 million in Q3 2025, $26.7 million for Q2 2025, and $24.2 million during Q1 2025.